alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7351 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7351

 To allow individuals with disabilities to campaign for elected office 
         without losing access to federally supported benefits.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 14, 2024

 Ms. Dean of Pennsylvania (for herself and Ms. Scanlon) introduced the 
 following bill; which was referred to the Committee on Oversight and 
                             Accountability

_______________________________________________________________________

                                 A BILL

 
 To allow individuals with disabilities to campaign for elected office 
         without losing access to federally supported benefits.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Removing Access Barriers to Running 
for Elected Office for People with Disabilities Act''.

SEC. 2. DISREGARDING CAMPAIGN WORK PERFORMED BY INDIVIDUALS WITH 
              DISABILITIES FOR PURPOSES OF FEDERALLY SUPPORTED 
              BENEFITS.

    (a) In General.--Any campaign work performed by a qualified 
individual, and any compensation received by such individual for such 
work, shall be disregarded for the purpose of determining such 
individual's eligibility for, and amount of, benefits or assistance 
under any Federal program or under any State or local program financed 
in whole or in part with Federal funds.
    (b) Definitions.--In this section:
            (1) Campaign work.--The term ``campaign work'' means work 
        performed by an individual as a candidate for an elected 
        Federal, State, or local office.
            (2) Qualified individual.--The term ``qualified 
        individual'' means an individual who is entitled to a benefit 
        under title II or XVI of the Social Security Act (42 U.S.C. 401 
        et seq., 1381 et seq.) by reason of a disability.
                                 <all>
```
I 

118TH CONGRESS 

2D SESSION H. R. 7402 

To reimburse the State of Texas for expenses incurred for activities conducted 

relating to securing the southern international border of the United 

States, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 15, 2024 

Mr. WILLIAMS of Texas introduced the following bill; which was referred to 

the Committee on the Judiciary 

A BILL 

To reimburse the State of Texas for expenses incurred for 

activities conducted relating to securing the southern 

international border of the United States, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Operation Lone Star 

5 Reimbursement Act’’. 

6 SEC. 2. FINDINGS. 

7 Congress finds the following: 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7402 IH

1 (1) The Federal Government is primarily re2 sponsible for securing the borders of the United 

3 States at and between ports of entry. 

4 (2) Due to the lack of action by the Federal 

5 Government, the State of Texas has been forced to 

6 continually appropriate funds to secure the southern 

7 border of the United States. 

8 (3) Texas has taken these actions to help main9 tain safety and security for all citizens across the 

10 United States by protecting against the criminal 

11 acts of— 

12 (A) human trafficking; 

13 (B) sex trafficking; 

14 (C) drug proliferation; 

15 (D) illicit movement of weapons and con16 traband; 

17 (E) criminal organizations; and 

18 (F) unlawful entry. 

19 (4) The amount the State of Texas spent on 

20 border security to combat these criminal acts was— 

21 (A) more than $800,000,000 in the years 

22 2020 through 2021; and 

23 (B) more than $2,926,400,000 in the 

24 years 2022 through 2023. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 7402 IH

1 (5) The State of Texas plans to spend an addi2 tional $4,600,000,000 to secure the border in the 

3 years 2024 through 2025. 

4 SEC. 3. REIMBURSEMENTS FOR THE STATE OF TEXAS. 

5 (a) APPLICATION FOR REIMBURSEMENT.—The Gov6 ernor of Texas shall submit to the Secretary of Homeland 

7 Security and the Secretary of the Treasury an application 

8 for reimbursement, which shall include— 

9 (1) a list of expenses incurred by the State of 

10 Texas for activities conducted relating to securing 

11 the southern international border of the United 

12 States during the years 2020, 2021, 2022, 2023, 

13 and 2024; and 

14 (2) the total amount of expenses incurred for 

15 such activities. 

16 (b) REIMBURSEMENT.—Not later than 60 days after 

17 the State of Texas submits an application for reimburse18 ment pursuant to subsection (a), the Secretary of the 

19 Treasury shall pay to the State of Texas, out of any 

20 amounts in the Treasury not otherwise appropriated, an 

21 amount equal to the total amount of expenses described 

22 in subsection (a)(2). 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
Exhibit 15.4




[BDO Auditores S.L.P. Letterhead]




CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM




We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (File Nos. 333-187533, 333-102288 and 333-92491) pertaining to the Employee Stock Option plans of Ellomay Capital Ltd. (the “Company”) and Forms F-3 (File Nos. 333-199696 and 333-144171) of the Company of our report dated April 29, 2015 with respect to the 2014 financial statements of Rodríguez II Parque Solar, S.L. included in the Annual Report on Form 20-F of the Company for the year ended December 31, 2015.




/s/ BDO Auditores S.L.P.


BDO Auditores S.L.P.





Spanish Certified Public Accountants





Madrid, Spain


March 21, 2016
**Exhibit
      32(b)**





**Certification
      of Chief Financial Officer Pursuant to 18 U.S.C. § 1350**


**(Section
      906 of the Sarbanes-Oxley Act of 2002)**





Pursuant
      to 18 U.S.C. § 1350, the undersigned officer of Republic Bancorp Inc. (the
“Company”) hereby certifies, to such officer’s knowledge, that the Company’s
      Quarterly Report on Form 10-Q for the quarterly period ended September 30,
      2006
      (the “Report”) fully complies with the requirements of Section 13(a) or 15(d),
      as applicable, of the Securities Exchange Act of 1934 and that the information
      contained in the Report fairly presents, in all material respects, the financial
      condition and results of operations of the Company.








Date:
                November 8, 2006
            /s/
                Thomas F. MenacherName:
                Thomas F. MenacherTitle:
                Executive Vice President, Treasurer and Chief Financial
                Officer





The
      foregoing certification (i) accompanies the filing and is being furnished solely
      pursuant to 18 U.S.C. § 1350, (ii) will not be deemed “filed” for purposes of
      Section 18 of the Securities Exchange Act of 1934, or otherwise subject to
      the
      liability of that section, and (iii) will not be deemed to be incorporated
      by
      reference into any filing under the Securities Act of 1933 or the Exchange
      Act,
      except to the extent that the registrant specifically incorporates it by
      reference.








A
      signed
      original of this written statement required by Section 906, or other document
      authenticating, acknowledging, or otherwise adopting the signature that appears
      in typed form within the electronic version of this written statement required
      by Section 906, has been provided to Republic Bancorp Inc. and will be retained
      by Republic Bancorp Inc. and furnished to the Securities and Exchange Commission
      or its staff upon request.
# EUR-Lex - 31992L0011 - EN

Avis juridique important

*|*

# 31992L0011

**Council Directive 92/11/EEC of 3 March 1992 amending Directive 89/396/EEC on indications or marks identifying the lot to which a foodstuff belongs **

*
Official Journal L 065 , 11/03/1992 P. 0032 - 0032 *

COUNCIL DIRECTIVE 92/11/EEC of 3 March 1992 amending Directive 89/396/EEC on indications or marks identifying the lot to which a foodstuff belongs

THE COUNCIL OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100a thereof,

Having regard to the proposal from the Commission (1),

In cooperation with the European Parliament (2),

Having regard to the opinion of the Economic and Social Committee (3),

Whereas it is necessary to take account of the insurmountable technical problems which made it impossible to implement Directive 89/396/EEC (4), as amended by Directive 91/238/EEC (5), by 20 June 1991; whereas it is therefore necessary to postpone the implementation date,

HAS ADOPTED THIS DIRECTIVE:

Article 1

The second indent of the first subparagraph of Article 7 of Directive 89/396/EEC is hereby replaced by the following:

'- prohibit trade in products not complying with this Directive with effect from 1 July 1992. However, trade in products placed on the market or labelled before that date and not conforming with this Directive may continue until stocks run out.'

Article 2

This Directive is addressed to the Member States. Done at Brussels, 3 March 1992. For the Council

The President

Arlindo MARQUES CUNHA

(1) OJ No C 219, 22. 8. 1991, p. 11. (2) OJ No C 305, 25. 11. 1991, p. 54 and Decision of 12 February 1992 (not yet published in the Official Journal). (3) OJ No C 40, 17. 2. 1992, p. 12. (4) OJ No L 186, 30. 6. 1989, p. 21. (5) OJ No L 107, 27. 4. 1991, p. 50.
§ 349.14 Ophthalmic emollients. The active ingredients of the product consist of any of the following: ( a ) Lanolin preparations: ( 1 ) Anhydrous lanolin, 1 to 10 percent in combination with one or more oleaginous emollient agents included in the monograph.
( 2 ) Lanolin, 1 to 10 percent in combination with one or more oleaginous emollient agents included in the monograph.
( b ) Oleaginous ingredients: ( 1 ) Light mineral oil, up to 50 percent in combination with one or more other emollient agents included in the monograph.
( 2 ) Mineral oil, up to 50 percent in combination with one or more other emollient agents included in the monograph.
( 3 ) Paraffin, up to 5 percent in combination with one or more other emollient agents included in the monograph.
( 4 ) Petrolatum, up to 100 percent.
( 5 ) White ointment, up to 100 percent.
( 6 ) White petrolatum, up to 100 percent.
( 7 ) White wax, up to 5 percent in combination with one or more other emollient agents included in the monograph.
( 8 ) Yellow wax, up to 5 percent in combination with one or more other emollient agents included in the monograph.
38730.

#### WESTERN *&*ATLANTIC RAILROAD v. TREADAWAY.

Decided April 4, 1961

Rehearing denied April 14, 1961.

*Hugh M. Dorsey,*Jr. *Neel, Ault & Whiteside, E. S. Ault, for*plaintiff in error.

*Henson, Greene & Greene, James E. Greene,*contra.

Jordan, Judge.

The evidence adduced on the trial of the case showed that the cows were killed about 7:20 p.m. on October 14, 1959, that it was dark and raining, and that the track at the place of the killing was straight. The engineer in charge of the train, testified that it was running about 60 miles per hour; that he was looking ahead and did not see the cows until they were about 300 feet, more or less, from them; that he *512first saw an object and applied the brakes,, and then .saw- that it-was cattle and commenced blowing the whistle, and the cows commenced running; that the train struck and-killed three.of the cows; and that on a dark, rainy night the headlights of the train would light up the track for approximately 300 or 400 feet. The fireman testified that he was looking ahead and did not see the cows until they were approximately 100 to 150 feet from them; that he and the engineer saw the cows at approximately the same time; and that he remarked to the engineer, “Look a yonder,” and the engineer put the brakes 'on emergency’ and blew the horn. The evidence indicated that the cattle dispersed as soon as the horn was sounded.

.Under these factp and circumstances the jury was authorized to find that the.engineer could, by the exercise of due care, have observed the dangerous situation of the cows in.time to have given sufficient warning to disperse them from the track. *Bugg v. Huffman,*33 Ga. App. 630. (127. S. E. 657). Accordingly, the verdict was. authorized by the evidence, and the trial court did not err in denying the defendant’s motion for judgment notwithstanding the verdict.

*Judgment affirmed.*

*Townsend, P. J., Carlisle and■ Frankum, JJ., conpwr\*
<PAGE>   1


                                   EXHIBIT 11
<TABLE>
                            STATEMENT RE COMPUTATION OF PER SHARE EARNINGS
<CAPTION>
                           For the three       For the three       For the nine        For the nine
                              months              months              months              months
                               ended               ended              ended                ended
                           September 30,       September 30,       September 30,       September 30,
                              Primary          Fully diluted          Primary          Fully diluted
<S>                          <C>                 <C>                 <C>                 <C>
Weighted average
shares
outstanding                  3,385,805           3,385,805           3,385,805           3,385,805

Dilutive effect of
common stock
equivalents                    246,599             246,599             180,171             246,599

Weighted average
common and common
equivalent shares
outstanding                  3,632,404           3,632,404           3,565,976           3,632,404
                             =====================================================================

Net Income                     $63,197             $63,197            $265,403            $265,403
                             =====================================================================

Net income per
common share                   $  0.02             $  0.02            $   0.07            $   0.07
                             =====================================================================
</TABLE>

                                      -11-
<PAGE>

                                                                    Exhibit 32.1

                                 PROTHERICS PLC

         CERTIFICATIONS PURSUANT TO RULE 13a-14(b) OF THE SECURITIES ACT
     OF 1934, AS AMENDED, AND 18 U.S.C. Section 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Report of Protherics PLC (the "Company") on Form
20-F for the year ended March 31, 2004, as filed with the Securities and
Exchange Commission (the "SEC") on the date hereof (the "Report"), Andrew J.
Heath, Chief Executive Officer of the Company, and Barrington M. Riley, Chief
Financial Officer of the Company, certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63
of Title 18, United States Code) that:

      (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934 (the "Exchange Act"); and

      (2) Information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Date: September 30, 2004                               /s/ Andrew J. Heath
                                                       -------------------------
                                                       Andrew J. Heath
                                                       Chief Executive Officer

                                                       /s/ Barrington M. Riley
                                                       -------------------------
                                                       Barrington M. Riley
                                                       Chief Financial Officer

                                       1
§ 520.88d Amoxicillin trihydrate soluble powder. ( a ) *Specifications.* Each gram of powder contains amoxicillin trihydrate equivalent to 115.4 milligrams (mg) amoxicillin.
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Related tolerances.* See § 556.38 of this chapter.
( d ) *Conditions of use in preruminating calves including veal calves* — ( 1 ) *Amount.* Administer 400 mg per 100 pounds of body weight twice daily by drench or in milk. Treatment should be continued for 48 hours after all symptoms have subsided but not to exceed 5 days.
( 2 ) *Indications for use.* Treatment of bacterial enteritis when due to susceptible *Escherichia coli* in preruminating calves including veal calves.
( 3 ) *Limitations.* Do not slaughter animals during treatment or for 20 days after the latest treatment. Federal law restricts this drug to use by or on the order of a licensed veterinarian
[57 FR 37319, Aug. 18, 1992; 57 FR 42623, Sept. 15, 1992; 58 FR 18304, Apr. 8, 1993, as amended at 60 FR 55658, Nov. 2, 1995; 62 FR 5525, Feb. 6, 1997; 79 FR 28817, May 20, 2014]
###### Editorial Note on Part 178

#### Editorial Note:

Nomenclature changes to part 178 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

#### § 178.3720 Petroleum wax, synthetic.

Synthetic petroleum wax may be safely used in applications and under the same conditions where naturally derived petroleum wax is permitted in subchapter B of this chapter as a component of articles intended to contact food, provided that the synthetic petroleum wax meets the definition and specifications prescribed in § 172.888 of this chapter.
§ 349.1 Scope. ( a ) An over-the-counter ophthalmic drug product in a form suitable for topical administration is generally recognized as safe and effective and is not misbranded if it meets each of the conditions in this part and each of the general conditions established in § 330.1.
( b ) References in this part to regulatory sections of the Code of Federal Regulations are to chapter I of title 21 unless otherwise noted.
C OURT OF A PPEALS FOR THE F IRST D ISTRICT OF T EXAS AT H OUSTON

O RDER Appellate case name: Ex parte Rickel Tonio Baker , Jr. Appellate case number: 01

- 22

- 00789

- CR , 01

- 22

- 00 7 9 0

- CR , 01

- 22

- 007 9 1

- CR Trial court case number: 22

- DCR

- 099972 , 20

- DCR

- 092879 A , 20

- DCR

- 092879B Trial court: 240th District Court of Fort Bend Cou nty Appellant filed a notice of appeal from the trial court’s October 21, 2022 order ( s ) denying his application s for writ of habeas corpus. The complete appellate record has been filed with t his Court. Aft er a review of the appellate record, the Court desires briefing in this matter
. See T EX . R. A PP . P
. 31.1. A ppellant is ordered to file a brief within twenty days of the date of this order in support of his applications for writ of habeas co rpus . See T EX . R. A PP . P. 31.1. The State’s brief, if any, is due to be filed no later than twenty days from the filing of appellant’s brief. It is so ORDERED. Judge’s signature: /s/ Veronica Rivas

- Molloy

Acting individually
Date: January 19, 2 023
#### Hatfield *v.*Brown et al.

[No. 18,967.

Filed February 20, 1901.]

From the Huntington Circuit Court.

*Reversed.*

*J. T.*Alexanderj *M. L. Spencer*and *W. A.*Branyan, for appellant.

*J. Q. Cline*and *J. C. Branyan,*for appellees.

Baker, J.

The parties agree, and correctly so, that this case is governed by the decision in *Hatfield*v. *DeLong, ante,*207. On the authority of that decision, the judgment herein is reversed, with directions to overrule the demurrer to the complaint.
<PAGE>   1
                                                                    EXHIBIT 23.1

              CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS



We have issued our reports dated September 29, 1997, accompanying the
consolidated financial statements of SI Technologies, Inc. and Subsidiaries
appearing in the 1997 Annual Report of the Company to its shareholders included
in the Annual Report on Form 10-KSB for the year ended July 31, 1997 which are
incorporated by reference in this Registration Statement. We consent to the
incorporation by reference in the Registration Statement of the aforementioned
reports and to the use of our name as it appears under the caption "Experts."

GRANT THORNTON LLP



Seattle, Washington
September 11, 1998
[DO NOT PUBLISH]

In the

United States Court of Appeals

For the Eleventh Circuit

____________________

No. 24-11403

Non-Argument Calendar

____________________

JENNY LINDSAY, 

Plaintiff-Appellant,

versus

EMORY UNIVERSITY SCHOOL OF LAW, et al.,

Defendants,

EMORY UNIVERSITY, 

DIRECTOR HEIDI FAENZA, 

Individually, as former Director of Georgia Office 

of Bar Admissions, 

DIRECTOR JOHN EARLES, 

Individually, and in his official capacity as Director 

USCA11 Case: 24-11403 Document: 19-1 Date Filed: 08/14/2024 Page: 1 of 3
2 Opinion of the Court 24-11403

of Georgia Office of Bar Admissions,

Defendants-Appellees.

____________________

Appeal from the United States District Court

for the Northern District of Georgia

D.C. Docket No. 1:22-cv-00886-WMR

____________________

Before LAGOA, BRASHER, and ABUDU, Circuit Judges.

PER CURIAM:

Jenny Lindsay, pro se, appeals (1) the district court’s September 11, 2023 order and the related final judgment granting Emory 

University’s (“Emory”) and Heidi Faenza and John Earles’s motions to dismiss Lindsay’s first amended complaint and strike her 

second amended complaint, and terminating as moot her motions 

for default judgment and to correct filing; and (2) the district court’s 

March 27, 2024 order partially granting her motion to alter or 

amend the judgment. Those orders are not final or appealable, 

however, because the March 27 order reinstated Emory as a defendant, and, thus, rendered the proceedings non-final. See 

28 U.S.C. § 1291; Acheron Cap., Ltd. v. Mukamal, 22 F.4th 979, 986 

(11th Cir. 2022) (stating that a final order ends the litigation on the 

merits and leaves nothing for the court to do but execute its judgment). 

USCA11 Case: 24-11403 Document: 19-1 Date Filed: 08/14/2024 Page: 2 of 3
24-11403 Opinion of the Court 3

Nor did the district court certify its September 11, 2023 judgment for immediate review under Federal Rule of Civil Procedure 

54(b). See Supreme Fuels Trading FZE v. Sargeant, 689 F.3d 1244, 1246 

(11th Cir. 2012) (noting that an order that disposes of fewer than all 

claims against all parties to an action is not immediately appealable 

absent certification pursuant to Rule 54(b)). Further, the district 

court’s September 11 and March 27, 2024 orders are not effectively 

unreviewable on appeal from a final order resolving the case on the 

merits. See Plaintiff A v. Schair, 744 F.3d 1247, 1252-53 (11th Cir. 

2014) (explaining that a ruling that does not conclude the litigation 

may be appealed under the collateral order doctrine if it, inter alia, 

is “effectively unreviewable on appeal from a final judgment”).

Accordingly, this appeal is DISMISSED, sua sponte, for lack 

of jurisdiction. All pending motions are DENIED as moot. No petition for rehearing may be filed unless it complies with the timing 

and other requirements of 11th Cir. R. 40-3 and all other applicable 

rules.

 

USCA11 Case: 24-11403 Document: 19-1 Date Filed: 08/14/2024 Page: 3 of 3